Edition:
United States

Silence Therapeutics PLC (SLN.L)

SLN.L on London Stock Exchange

100.50GBp
19 Jan 2017
Change (% chg)

-1.38 (-1.35%)
Prev Close
101.88
Open
101.00
Day's High
101.00
Day's Low
99.00
Volume
25,943
Avg. Vol
24,924
52-wk High
149.75
52-wk Low
96.62

SLN.L

Chart for SLN.L

About

Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a... (more)

Overall

Beta: 0.96
Market Cap(Mil.): £71.11
Shares Outstanding(Mil.): 69.80
Dividend: --
Yield (%): --

Financials

  SLN.L Industry Sector
P/E (TTM): -- 45.12 30.76
EPS (TTM): -0.10 -- --
ROI: -12.11 -1.32 14.89
ROE: -12.11 -0.98 16.30

BRIEF-Silence Therapeutics Plc reports 9.21 percent stake in Arrowhead Pharmaceuticals Inc as of Jan 3 - SEC filing

* Silence Therapeutics Plc reports 9.21 percent stake in Arrowhead Pharmaceuticals Inc as of Jan 3 - SEC filing

Jan 13 2017

BRIEF-Silence Therapeutics buys stake in Arrowhead Pharmaceuticals

* Acquired stake in arrowhead pharmaceuticals, inc of 6,006,359 common shares, representing 8.4 pct of common share capital

Jan 09 2017

Earnings vs. Estimates